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Available online 13 September 2013Abstract MicroRNA-137 (miR-137) has been shown to play an important role in the differentiation of neural stem cells.
Embryonic stem (ES) cells have the potential to differentiate into different cell types including neurons; however, the
contribution of miR-137 in the maintenance and differentiation of ES cells remains unknown. Here, we show that miR-137
is mainly expressed in ES cells at the mitotic phase of the cell cycle and highly upregulated during differentiation. We
identify that ES cell transcription factors, Klf4 and Tbx3, are downstream targets of miR-137, and we show that
endogenous miR-137 represses the 3′ untranslated regions of Klf4 and Tbx3. Transfection of ES cells with mature miR-137
RNA duplexes led to a significant reduction in cell proliferation and the expression of Klf4, Tbx3, and other self-renewal
genes. Furthermore, we demonstrate that increased miR-137 expression accelerates differentiation of ES cells in vitro.
Loss of miR-137 during ES cell differentiation significantly impeded neuronal gene expression and morphogenesis. Taken together,
our results suggest that miR-137 regulates ES cell proliferation and differentiation by repressing the expression of downstream
targets, including Klf4 and Tbx3.
© 2013 Elsevier B.V. All rights reserved.Introduction
Embryonic stem (ES) cells have the remarkable ability
to replicate indefinitely while retaining the capacity to
differentiate into functionally distinct cell types including
neurons. The pluripotency and self-renewal of ES cells
are regulated by a core transcriptional circuitry comprising
of transcription factors, chromatin modulators, and small
non-coding microRNAs (miRNAs) (Dejosez and Zwaka, 2012; LiAbbreviations: ES cells, embryonic stem cells; NC, neuronally differe
miRNA, microRNA; 3′UTR, 3′ untranslated region; LSD1, lysine specific
transcription; qPCR, quantitative real-time polymerase chain reaction
dihydrochloride; PBS, phosphate buffered saline; SSC, saline-sodium citr
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http://dx.doi.org/10.1016/j.scr.2013.09.001et al., 2012; Pauli et al., 2011). The self-regulatory networks
formed by transcription factors such as Oct4, Sox2, Nanog, Klf4,
Esrrb, Tbx3, and Tcf3 regulate a wide range of downstream
genes required for self-renewal and pluripotency (Boyer et al.,
2005; Chambers and Tomlinson, 2009; Ivanova et al., 2006;
Kim et al., 2008; Silva and Smith, 2008). In addition to the
transcription factors, epigenetic changes associated with
posttranslational modifications of histone proteins are known
to regulate gene expression in ES cells (Li et al., 2012).ntiated ES cells; EB, embryoid body; LIF, leukemia inhibitory factor;
demethylase 1; Tuj1, neuronal class III β-tubulin 3; RT, reverse
; ddPCR, droplet digital PCR; DAPI, 4,6-diamidino-2-phenylindole
ate.
dicine, Annenberg 14-72, Box 1137, One Gustave L. Levy Place, New
1300 K. Jiang et al.Moreover, by directly interacting with ES cell transcription
factors, miRNAs are shown to regulate the central signaling
circuitry in ES cells (Pauli et al., 2011). The genetic
deletion of key miRNA processing enzymes such as Dicer or
Dgcr8 has been shown to impair cell cycle progression and
cause defective differentiation (Murchison et al., 2005;
Wang et al., 2008). Studies on the role of miRNAs in ES cells
suggest that the regulatory function of the miRNA is often
regulated through, and controlled by, various transcrip-
tion factors important for self-renewal and pluripotency
(Marson et al., 2008; Melton et al., 2010; Tay et al., 2008;
Xu et al., 2009). An understanding of the interactions
among these factors will be critical for the development of
improved strategies to reprogram differentiated cells or
induce differentiation of pluripotent ES cells to function-
ally distinct cell types.
miRNAs are short non-coding RNAs that can modulate
gene expression by binding to the complementary se-
quences on target sites in the 3′ untranslated regions
(UTRs) of messenger RNA (Bartel, 2004). There is strong
evidence that miRNAs play an important role in the
maintenance of ES cells (Pauli et al., 2011). In ES cells, a
majority of the miRNA species are produced by 4 miRNA
loci (the miR-21, the miR-17-92 cluster, the miR-15b-16
cluster and the miR-290-295 cluster) that regulate cell
cycle progression and oncogenesis (Calabrese et al., 2007).
During differentiation, a number of miRNAs exhibit distinct
expression patterns and have been shown to fine tune or
restrict cellular identities by targeting important tran-
scription factors or key pathways (Stefani and Slack, 2008).
For example, miRNA-145 has been shown to repress Oct4,
Sox2, and Klf4 during differentiation of human ES cells
into mesoderm and ectoderm lineages (Xu et al., 2009).
Furthermore, miR-134, miR-296, and miR-470 target the
transcription factors Nanog, Oct4, and Sox2 to promote
retinoic-acid-induced differentiation of mouse ES cells (Tay et
al., 2008). The contribution of additional miRNAs involved in
the direct repression of ES cell transcription factors during
neuronal differentiation remains unknown. We searched for
miRNAs that show increased expression levels during neuronal
differentiation and are predicted to target ES cell genes. The
expression of miR-137 has been found to increase during
differentiation of neural stem cells into neurons (Sun et al.,
2011b; Szulwach et al., 2010). Moreover, miR-137 is one of
the two miRNAs in ES cells that are co-occupied by the key
transcription factors: Oct4, Sox2, and Nanog (Boyer et al.,
2005). These findings suggest thatmiR-137may be an important
component of the transcriptional regulatory circuitry, and that
temporal expression ofmiR-137may influence proliferation and
differentiation of ES cells.
Here, we show that miR-137 is mainly expressed in ES
cells at mitotic stages of the cell cycle and is significantly
upregulated when ES cells are differentiated into neuronal
lineage. We demonstrated that miR-137 directly targets the
ES cell transcription factors, Klf4 and Tbx3, as well as a
known miR-137 target, lysine specific demethylase 1 (LSD1)
(Balaguer et al., 2010; Sun et al., 2011b). The repressive
effect of miR-137 is mediated by its binding to the target
sites present in the 3′ untranslated regions (3′UTRs) of the
mRNAs. Furthermore, we found that miR-137 disrupts ES
cell self-renewal and accelerates differentiation of ES cells
in vitro.Materials and methods
ES cell culture and differentiation
R1 ES (ATCC) and Dgcr8−/− (Novus Biologicals) cells were
maintained on mitomycin C treated MEF feeder layers and
differentiated in vitro as described previously (Melton et
al., 2010; Nair, 2006). Briefly, undifferentiated ES cells
were grown on gelatin-coated tissue culture plates in the
presence of 1000 U/ml leukemia inhibitory factor (LIF;
Chemicon) in ES cell medium. To induce embryoid body
(EB) formation, the cells were trypsinized and dissociated
to a single-cell suspension and plated in ES cell medium
without LIF onto non-adherent bacterial culture dishes at a
density of 2–2.5 × 106 cells/dish. Four-day-old EBs were
plated onto adherent tissue culture dishes and maintained
in ES cell medium for 24 h. The selection of nestin-positive
cells was initiated by replacing the ES cell medium with
serum-free insulin/transferrin/selenium medium. Cells grown
in differentiation medium for 12–14 days were used in all
experiments.Western immunoblotting
Total cell extracts were prepared and Western immunoblotting
was carried out as described in our previous publication (Nair et
al., 2012). Western blots of Klf4, Tbx3, LSD1, CoREST, RXRα,
GAPDH, and β-actin were performed using anti-Klf4 (Millipore;
09-821), anti-Tbx3 (SCB: sc-48781), anti-LSD1 (CST; 2139), anti-
CoREST (Millipore; 07-455), anti-RXRα (SCB; sc-553), anti-
GAPDH (SCB; sc-166545), and β-actin (SCB; sc-166545)
antibodies. All horseradish peroxide-conjugated secondary
antibodies were from Santa Cruz Biotechnology.Quantitative real-time PCR
Quantitative real-time PCR (RT-qPCR) was carried out to
measure gene expression as described in our previous publica-
tion (Nair et al., 2012). Briefly, RNA was isolated using an
Absolutely RNA preparation kit (Agilent Technologies) and
reverse transcribed using the Superscript™ III first-strand
synthesis system (Invitrogen). SYBR green qPCR reactions on
resulting cDNAs were performed on an ABI 7900HT (Applied
Biosystems). Gene-specific primers used for RT-qPCR are shown
in Table 1. β-Actin, α-tubulin, and Rps11 were used as internal
normalization controls.
For RT-qPCR assays of miRNAs, total RNA was prepared
using mirVANA miRNA isolation kit (Ambion). cDNA was
synthesized from 100 ng of total RNA using miRNA specific
RT primers and the expression was quantified using TaqMan
MicroRNA Kits according to the manufacturer's protocol
(Applied Biosystems). RT-qPCR assays using TaqMan Assay
Kits, mmu-miR137 (ID 001129), hsa-miR16 (000396), and
mouse snoRNA (001232) were used to determine the
expression of miR-137, miR-16, and snoRNA, respectively.
Relative fold mRNA and miRNA levels were determined by
the 2−ΔΔCT (cycle threshold) method (Nair et al., 2012).
The expression levels of each miRNA in undifferentiated ES
cells (ESC) were arbitrarily set to one.
Table 1 RT-qPCR primer sequences.
Gene name Sense primer Antisense primer
Klf4 GTCAAGTTCCCAGCAAGTCAG CATCCAGTATCAGACCCCATC
Tbx3 TGGCTCAGTGTCCTTGTCAC ACTGGAATGGAGAGACCTTGG
LSD1 CACAGCAGTCCCCAAGTATGT GCCTCTGCTGTCAAACTAGGA
Oct 4 CCCACTTCACCACACTCTACT GCTCCAGGTTCTCTTGTCTA
Nanog CCACCAGGTGAAATATGAGAC GGCTCACAACCATACGTAAC
Sox2 CCGTGATGCCGACTAGAAAAC AGCGCCTAACGTACCACTAG
REST AAGGAACCACCTCCCAGTATG CGTCTGAGCAACCTCAATCTG
CoREST GCCTCATTCACCTTTCCTTC CCAACCCTTCTTTCTCCAAAC
Calb1 TGCCAGAGAGTATGACCATAG GGAAGTAGGCAAACTAGACAC
Kcnn1 TCACCTTCAACACACGCTTC GCTGGTCACTTCCTGCTTATC
RXR GCAAACACAAGTACCCTGAGC CATCTCCATGAGGAAGGTGTC
Scn3a TTGCCTAACATGATACAACTC TTGGCTCAATAACGAAGTAG
Slc1a3 TGTGCTTGTTTATGTCCCTACC TCTCCTGCTGTGTTTTCTTCC
NeuroG2 GACTCCACTTCACAGAGCAGAG CACGCCATAGTCCTCTTTGAC
Rps11 GCACATTGAATCGCACAGTC CGTGACGAAGATGAAGATGC
α-Actin CTGCGCAAGTTAGGTTTTGTCAA GCTGCCTCAACACCTCAAC
β-Tubulin AG CTGGAGCAGTTTGACGACAC TGCCTTTGTGCACTGGTATG
Brachyury TTACACACCACTGACGCACAC AGGCTATGAGGAGGCTTTGG
Sox17 GCAACTACCCCGACATTTGAC CAAAACAGCTTGACGCTAAGG
Mixl1 TCTTCCGACAGACCATGTACC TGAAATGACTTCCCACTCTGG
Sox1 TCTCCAACTCTCAGGGCTACA ACTTGACCAGAGATCCGAGG
Tuj1 CCACCTTCATTGGCAACAGC GCTTCCGATTCCTCGTCATCA
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miRNA levels were measured by digital PCR using the
QuantaLife droplet digital PCR (ddPCR) system (Nair et al.,
2012). Briefly, 20 μl of ddPCR mixtures was prepared by
combining the respective reverse transcription (RT) product,
primers, and probes with the QuantaLife master mix. Approx-
imately 10,000 to 14,000 monodispersed droplets for each
sample were prepared using the QuantaLife droplet generator.
The droplets were transferred to a 96-well PCR plate and
amplified to endpoint using the following conditions: 95 °C for
10 min, 40 cycles of 94 °C for 30 s, 60 °C for 1 min, and 98 °C
for 10 min in a standard thermal cycler (PTC100; MJ Research).
Plates were read in a QuantaLife droplet reader, and the
concentrations (copy numbers) of the targets in the samples
were determined using QuantaSoft software. The expression
levels of each miRNA in vehicle-treated cells (control) were
arbitrarily set to one.
3′UTR luciferase reporter constructs
To make the luciferase reporter constructs with LSD1 3′
UTR, full-length cDNA, corresponding to the 3′UTR of LSD1
(2665–2999 bp), was amplified from mouse ES cell mRNA
by PCR. The product was sub-cloned into the pDrive vector
(Qiagen), and we confirmed the sequences. The 3′UTR
was then excised by Mlu1-HindIII digestion and cloned into
the pMIR-REPORT Luciferase vector (Ambion). To generate
a LSD1 3′UTR luciferase reporter construct-lacking miR-
137 binding site, we deleted the miR-137 target site
5′-TAGCAATA-3′ by using a site-directed mutagenesis kit
with overlapping mutated primers 5′-CTGCCACGTAAG
CAAGCTCTTCCTAGATCCTACTGAGAAACTCCATG-3′ and 5′-
CATGGAGTTTCTCAGTAGGATCTAGGAAGAGCTTGCTTACGTGGCAG-3′, according to the manufacturer's instructions
(Promega). Klf4 3′UTR luciferase reporter was constructed
by cloning the PCR-amplified DNA corresponding to 714–
790 bp of mouse Klf4 3′UTR, flanking the miR-137 binding
site (753–759 bp) into the pDrive vector. The Klf4 3′UTR
was then excised by HindIII/Spe1 digestion and cloned
into the pMIR-REPORT luciferase vector. We deleted the
miR-137 target site 5′-GCAATAA-3′ at the KLf4 3′UTR by
using a site-directed mutagenesis kit with overlapping
mutated primers 5′-TTATGCACTGTGGTTTCAGATGTTTTGT
ACAAT-GGTTTATT-3′ and 5′-AATACGTGACACCAAAGTCTAC
AAAACATGTTACCAAATAA-3′. Nucleotide sequences of all
3′UTR constructs were confirmed by DNA sequencing. The Tbx3
3′UTR wild type with miR-137 binding site (8 bp GCAATAAC,
862–869) and Tbx3 3′UTR with mutant miR-137 sites (866–
869 bp), Oct4 3′UTR, and Sox2 3′UTR constructs used in the
study were reported previously (Xu et al., 2009; Zhang et al.,
2011).
Luciferase reporter assay
ES cells growing on gelatinized plates in LIF media were used
in transfection experiments. We plated 30,000 wild type
(R1 ES) or 40,000 Dgcr8−/− ES cells per well in a 48-well plate
and let them grow for at least 16 h before transfection.
For transfection experiments, we transfected a mixture of
250 ng of reporter to each well using Lipofectamine 2000,
according to the manufacturer's instructions (Invitrogen).
The pSV-β-Galactosidase Vector (Promega) was used as a
control plasmid for monitoring transfection efficiencies. In
co-transfection experiments, luciferase reporters were
transfected with 10–200 nM of mature miR-137 RNA duplexes
(UUAUUGCUUAAGAAUACGCGUAG; Dharmacon, C-310413-05),
miR-137 inhibitor (Dharmacon, IH-310413-07), or a combination
1302 K. Jiang et al.of both using Lipofectamine 2000. Cells were lysed 24–48 h
later, and processed for luciferase and β-galactosidase assays
using Dual-Luciferase Reporter Assay System (Promega) and
β-Galactosidase Enzyme Assay System (Promega), respectively.
The luciferase activity was measured using a Mithras LB 940
luminometer (Berthold Technologies), and β-galactosidase
activity was measured at 420 nm using a spectrophotometer
(Spectra Max Gemini XS, Molecular Devices).
Fluorescent in situ hybridization
Mouse ES cells were grown on gelatin-coated cover glasses
which were fixed and permeabilized as described previ-
ously (Nair et al., 2012). For the detection of miR-137, the
cells were hybridized with 5′-fluorescein labeled LNA
detection probe (Exiquon, #38510-04) overnight in 50%
formamide/5× SSC at 50 °C. The cells were washed three
times with 50% formamide/2× saline-sodium citrate (SSC),
three times with 2× SSC, and three times 0.2× SSC at
50 °C. The cells were washed with phosphate buffered
saline containing 0.1% Tween 20 (PBST), and the nuclei were
stained with 1 μg/ml (in PBS) of the fluorescent DNA dye 4,
6-diamidino-2-phenylindole dihydrochloride (DAPI) for 10 min
and mounted in the Vectashield (Vector Laboratories) mount-
ing medium. The slides were examined under an Olympus
(BX65) upright epifluorescence microscope.
Alkaline phosphatase staining
R1 ES cells were transfected with mature miR-137 duplexes,
inhibitor, or a combination of both, and grown in complete ES
medium and LIF for 5 days. Staining for alkaline phosphatase in
these cells was carried out using an alkaline phosphatase
detection kit according to the manufacturer's instructions
(Chemicon, Millipore).
Immunocytochemistry
Cells were permeabilized and incubated with primary anti-
bodies at 4 °C overnight as described previously (Nair et al.,
2012). Primary antibodies used were a rabbit polyclonal
anti-LSD1 (dilution 1:400), anti-Tuj1 mouse monoclonal anti-
body (Covance; MMS-435P; 1:1000), anti-Nanog (BD Biosci-
ence; 560259; 1:400), anti-histone H3 (CST; 9715; 1:500), and
anti-cytochrome c monoclonal antibody (BD Pharmingen;
556432, 1:400). After washing with PBST (PBS with 0.1%
Tween20), the cells were incubated at room temperature for
2 h with Alexa Fluor 568 donkey anti-rabbit IgG or Alexa Fluor
488 goat anti-rabbit/mouse IgG (Molecular Probes, dilution
1:400) as indicated. The slides were processed and images
were acquired as described in our previous publication (Nair et
al., 2012).
Cell cycle synchronization
To synchronize cells to metaphase, R1 ES cells were first
grown to about 60% confluency in complete ES medium.
Prior to the addition of 100 ng/ml nocodazole or vincristine,
the medium was replaced with serum-free ES cell medium
and incubated for 16–18 h. Synchronization and cell cyclestate were confirmed as described previously (Nair et al.,
2012) and used for the analysis of miR-137 expression.
Cell proliferation assay
For cell proliferation analysis, cells were plated at a density of
2 × 104 cells/well on 6, 96-microwell cell-culture plates (in
100 μl of medium). The next day (D0), cells were transfected
withmaturemiR-137 RNA duplexes (100 nM),miR-137 inhibitor
(50 nM), or a microRNA inhibitor negative control (Dharmacon,
IN-001005-01; 50 nM) and grown for 5 days. Media was changed
daily and the cell proliferation was determined on day 0, 1, 2,
3, and 4 using CellTiter-Blue™ reagent (Promega, Madison, WI).
The fluorescence was quantified using a spectrofluorometer
(Spectra Max Gemini XS, Molecular Devices) by measuring the
fluorescence at excitation/emission wavelengths of 570/
590 nm. Data are expressed as a percentage of the
vehicle-treated controls, and values represent the
means ±s.e.m. from eight microwells from each of two
independent experiments (n = 16).
Statistical analysis
The data were analyzed using the GraphPad Prism data
analysis program (GraphPad Software, San Diego, CA). For
the comparison of statistical significance between two
groups, Student's t tests for paired and unpaired data were
used. For multiple comparisons, one-way ANOVA followed by
post hoc comparisons of the group means according to the
method of Tukey was used.
Results
miR-137 is enriched in ES cells at the mitotic phase
of the cell cycle
miRNAs are small non-coding RNAs that are shown to regulate
pluripotency and self-renewal by interacting with the 3′UTR of
key transcription factors in ES cells (Pauli et al., 2011). To
assess the potential miRNA interaction with key ES cell genes,
we sought miRNAs that are regulated by ES cell transcription
factors and could interact with RNA recognition sites in the 3′
UTR of these genes. We performed bioinformatics analyses
using TargetScan (Lewis et al., 2003) to identify potential
miRNA candidates that have the capacity to interact with the 3′
UTR of ES cell genes. One candidate miRNA, miR-137, was
selected for further analysis on the basis of its regulation by
Oct4, Sox2, and Nanog (Boyer et al., 2005) and the presence of
target sites in the 3′UTR of many pluripotency and self-renewal
genes (Ramalho-Santos et al., 2002; Wang et al., 2008), such as
Klf4, Klf2, Tbx3, Akt2, GSK-3β, Cdk6, Cdc42, and CCNY mRNA.
TaqMan reverse transcription-PCR, droplet digital PCR, and
in situ hybridizationwere used to analyzemiR-137 expression in
mouse ES cells. We also amplified miR-16 and snoRNA in these
samples. We found that miR-137 is expressed at relatively
low levels in undifferentiated R1 ES cells (Fig. 1A). In situ
hybridization of miR-137, coupled with analysis of the nuclear
morphology characteristics of the mitotic phase in ES cells
growing under self-renewal conditions, demonstrated that
miR-137 is highly expressed in cells at all stages of mitosis and
Figure 1 miR-137 is highly expressed in M phase ES cells. (A) The relative levels of miR-137 increased after the differentiation of ES
cells. In TaqMan real-time RT-qPCR, miR-137, miR-16, and snoRNA levels were quantified in undifferentiated (ESC) and neuronally
differentiated R1 ES cells (NC). The expression levels of each miRNA in undifferentiated ES cells (ESC) were arbitrarily set to one. The
error bar represents the standard deviation (SD) from three independent experiments. **, P b 0.001. (B) miR-137 is mainly expressed
in M phase cells. Expression of miR-137 in R1 ES cells growing under self-renewal condition was assessed by in situ hybridization using
fluorescein-labeled miR-137 detection probe (green), while the blue fluorescent signal was from nuclear DNA counterstained with
DAPI. Scale bar, 5 μm. (C) Increased expression of miR-137 in cells synchronized at metaphase by nocodazole and vincristine
treatment (100 ng/ml; 16 h) was confirmed by droplet digital PCR (ddPCR). Data are the means ± SD (n = 4) from two independent
experiments. *, P b 0.01.
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found that all cells showing mitotic nuclear morphology, as
described in our recent report (Nair et al., 2012), showed
increased expression of miR-137. These results suggest that
miR-137 is expressed in a cell cycle-dependent manner in ES
cells.
To further confirm the expression of miR-137 in mitotic
cells, we synchronized ES cells to G2/M phases of the cell
cycle and the expression of miR-137 was determined by two
independent methods such as qPCR and droplet digital dPCR
(ddPCR). As shown in Fig. 1C, cells treated with nocodazole
and vincristine showed significantly higher miR-137 expression
levels. However, no changes in the levels ofmiR-16, amicroRNA
highly expressed in ES cells were observed in cells synchronized
to G2/M phase (Fig. 1C). The localization of miR-137 in mitotic
cells by in situ hybridization (Fig. 1B) and the increased levels of
miR-137 in mitotically synchronized cells (Fig. 1C) suggest that
miR-137 is expressed in a cell cycle-dependent manner in ES
cells.
miR-137 has been shown to inhibit proliferation and induce
differentiation of tumor cells (Kozaki et al., 2008; Silber et al.,
2008). miR-137 is a known regulator of neuronal development
and its expression has been found to increase during neuronal
differentiation (Ripke et al., 2011; Silber et al., 2008; Smrt et
al., 2010; Sun et al., 2011a). We used a stage-controlled ES celldifferentiation protocol that includes EB formation, selection,
expansion of nestin positive cells, and differentiation into
neuronal cells (Nair, 2006). Consistent with reported studies,
we observed a significant increase (~27 fold) in miR-137
expression upon differentiation of ES cells into neural cells
(NC) (Fig. 1A). However, no increase in the levels of miR-16 was
observed between ES cells and neuronally differentiated cells
(Fig. 1A). These findings suggest that the proper temporal
expression of miR-137 may influence ES cell proliferation and
differentiation.miR-137 represses luciferase reporters containing
Klf4 and Tbx3 3′UTRs
miRNAs bind to partially complementary target sites present
in the 3′UTRs of messenger RNA, which results in either
degradation of the target mRNAs or translational repression of
the encoded proteins (Bartel, 2004). By bioinformatics analysis
using TargetScan, we found 971 conserved miR-137 targets in
the mouse genome and identified many potential candidate
mRNAs that have the capacity to directly interact with miR-137
in ES cells. Two candidate genes, Klf4 and Tbx3, were selected
for further analysis on the basis of their role in ES cell
self-renewal and pluripotency and the presence of target
1304 K. Jiang et al.“seed sequences” in the 3′UTR of these mRNAs (Fig. 2A). We
also used LSD1, a known miR-137 target (Balaguer et al., 2010;
Sun et al., 2011b), as a control. To investigate whether Klf4,
Tbx3, and LSD1 can be directly targeted by miR-137 in ESFigure 2 (A) The miR-137 target site in the Klf4, Tbx3, and LSD1 3′U
sites) were deleted in the mutant 3′UTR constructs. (B–G) miR-137 rep
Dgcr8−/− ES cells were co-transfected with indicated wild type 3′UTR re
and mature miR-137 RNA duplexes, miR-137 inhibitor, or a combin
transfection and represented as the relative level to cells transfected w
UTR luciferase construct was used as a miR-137 non-target control. The
(n = 6). Student's t test compared two data sets marked by brackets
the 3′UTRs of Klf4, Tbx3, and LSD1 in ES cells. R1 ES cells were tra
with nocodazole (100 ng/ml; 16 h) after 24 h of transfection. Th
reporters of Klf4 (I and J), Tbx3 (K and L), and LSD1 (M and N) reflec
from three independent experiments. Student's t test compared twcells, we constructed luciferase reporters that have either the
wild-type 3′UTR of these genes or the mutant 3′UTR with
altered or deleted miR-137 target sites (Fig. 2A). In order to
evaluate the specific function of miR-137, we used Dgcr8−/−TR as predicted by TargetScan. The underlined nucleotides (target
resses Klf4, Tbx3, and LSD1 3′UTR in the luciferase reporter assay.
porters or constructs with deleted miR-137 binding sites (3′UTRΔ),
ation of both. Luciferase activity was determined at 24 h after
ith the basal luciferase reporter without UTR (control). (H) Oct4 3′
error bar represents the SD of three independent experiments
in the panel. *, P b 0.001. (I–N) Endogenous miR-137 represses
nsfected with indicated 3′UTR reporter constructs and treated
e difference between 3′UTR mutant and wild-type luciferase
ts the magnitude of repression. The error bar represents the SD
o data sets marked by brackets in the panel. *, P b 0.01.
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endogenous miRNAs (Melton et al., 2010). Dgcr8−/− ES cells
were co-transfected with luciferase constructs and mature
miR-137 RNA duplexes, small, double-stranded RNA molecules,
designed to mimic endogenous mature miR-137 functions when
transfected into cells. A luciferase reporter with no 3′UTR,
which is resistant to any miRNA repression in ES cells (negative
control), and transfection without mature miR-137 RNA
duplexes (mock transfection) were used as controls. The
optimum concentration of mature miR-137 RNA duplexes
required for the repression of the reporter constructs was
determined by transfecting different concentrations ranging
from 10 to 200 nM with LSD1 3′UTR plasmid. We selected
100 nM of mature miR-137 RNA duplexes for further studies
based on the maximum repression observed with wild type
luciferase reporter activity without affecting the control and
mutant reporter expression. Transfection of miR-137 signifi-
cantly reduced the luciferase activity of the wild-type reporter
constructs of Klf4, Tbx3, and LSD1 (Figs. 2B, D, and F). No
reduced luciferase activity was observed when the constructs
were cotransfected with miR-137 inhibitor, a chemically
modified, single stranded nucleic acid that was designed to
specifically bind to and inhibit the activity of miR-137 (Figs. 2B,
D, and F). Moreover, cotransfection of mature miR-137 RNA
duplexes with miR-137 inhibitor completely abolished the
repression mediated by miR-137 (Figs. 2B, D, and F). Mutant
reporters and an Oct4 3′UTR luciferase reporter constructFigure 3 miR-137 represses endogenous Klf4, Tbx3, and LSD1 mRN
and LSD1 (C) in Dgcr8−/− ES cells transfected with mature miR-137 R
mRNA levels were determined by RT-qPCR after 48 h of transfection.
Western blotting following 48 h after transfection with mature mi
miR-137 inhibitor; lane 4, combination of both transfected cells. β-
LSD1 mRNA levels in miR-137 transfected cells correlates with the red
mRNA level measured in these cells remained unchanged in any of
(G) were significantly repressed in cells transfected with miR-137.
triplicate. Student's t test compared two data sets marked by brack
expression of Sox2 3′ UTR luciferase construct. The error bar represwhich lacks a miR-137 target site were not repressed by
miR-137. These results suggest that a target site is required for
the repression of the reporters by miR-137 (Figs. 2C, E, G, and
H). Taken together, these results show that miR-137 directly
targets Klf4, Tbx3, and LSD1 3′UTRs in ES cells.
We then studied the role of endogenous miR-137 in
repressing the Klf4, Tbx3 and LSD1 3′UTR reporters in wild
type ES cells (R1) under self-renewal conditions (Nair et al.,
2012). At 48 h after transfection, there was a small but
significant repression of the wild-type 3′UTR luciferase
reporter activities of Klf4, Tbx3, and LSD1 in comparison to
the no-UTR control (Figs. 2I, K, and M). In contrast, the
respective mutant reporters with deletion of the miR-137
target site had significantly less repression than the wild
type reporters (Figs. 2J, L, and N). We further addressed the
dependence of 3′UTR reporter repression with the level of
miR-137. The expression of miR-137 has been shown to be
upregulated by treatment with nocodazole (Fig. 1B). At 24 h
after transfection with 3′UTR constructs, the cells were
synchronized to M phase by treatment with nocodazole
as described previously (Nair et al., 2012). Nocodazole
treatment significantly increased the repression of 3′UTR
constructs compared to non-synchronized cells (Figs. 2I, K,
and M). However, no significant repression was observed
with mutant 3′UTR reporters (Figs. 2J, L, and N). The
correlation between the increased levels of miR-137 and the
repression of the wild type target 3′UTR reporters withoutA and protein. (A–C) Relative mRNA levels of Klf4 (A), Tbx3 (B),
NA duplexes, miR-137 inhibitor, or the combination of both and
(D) The Klf4, Tbx3, and LSD1 protein levels were determined by
R-137 RNA duplexes. Lane 1, control; lane 2, miR-137; lane 3,
Actin was used as loading control. Reduction of Klf4, Tbx3, and
uction of the corresponding proteins in these cells. (E) The Oct4
the treatment groups. (F–G) Expression of Nanog (F) and Sox2
All real-time PCR experiments were performed three times in
ets in the panel. *, P b 0.001. (H) miR-137 had no effect on the
ents the SD of three independent experiments (n = 6).
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treated cells suggests that endogenous miR-137 also targets
the 3′UTRs of Klf4, Tbx3, and LSD1.
Overexpression of miR-137 reduces the levels of
endogenous Klf4 and Tbx3 in ES cells
miRNAs can downregulate gene expression by one of two
post-transcriptional mechanisms: mRNA cleavage or transla-
tional repression (Bartel, 2004). Because the luciferase assay
does not readily distinguish between these mechanisms, we
further examined how miR-137 represses the endogenous
Klf4, Tbx3, and LSD1 in ES cells. The Dgcr8−/− ES cells were
transfected with mature miR-137 duplexes, and we mea-
sured the mRNA and protein levels of endogenous Klf4, Tbx3,
and LSD1. Cells transfected with miR-137 inhibitor and mock
transfections were used as controls. RT-qPCR and Western
blot analyses showed that the mRNA and protein levels of
Klf4, Tbx3, and LSD1 were significantly reduced in cells
transfected with mature miR-137 RNA duplexes compared to
controls (Figs. 3A–C, and D). However, the pluripotency
factor, Oct4, which lacks the miR-137 target site, remained
unchanged in these cells (Fig. 3E). Cotransfection of the
mature miR-137 duplexes with the miR-137 antisense inhibitor
abolished the gene repression caused by miR-137 (Figs. 3A–C,
and D). These findings indicate that Klf4, Tbx3, and LSD1 are
repressed by destabilization of their mRNAs by miR-137. These
results are also consistent with the capacity of endogenous
miR-137 in ES cells to repress ectopic 3′UTR reporters of Klf4,
Tbx3, and LSD1 (Figs. 2B, D, and F). We also observed the
downregulation of transcription factors Nanog and Sox2 in cells
transfected with miR-137 (Figs. 3F and G). However, the
absence of a miR-137 target site in Nanog and Sox2 and the
observation that Sox2 3′UTR luciferase reporter was not
repressed by miR-137 (Fig. 3H) suggest that Sox2 is not a direct
target of miR-137, and the repression observed in these cells
may be mediated by an indirect effect of miR-137.
Overexpression of miR-137 modulates the
proliferation of R1 ES cells
The cell cycle-dependent expression of miR-137 in ES cells and
its upregulation during differentiation suggest a functional role
for miR-137 in ES cell self-renewal as well as in differentiation.
To determine the role of miR-137 in cell proliferation, R1 ES
cells growing under self-renewal conditions were transfected
with mature miR-137 duplexes, and cell proliferation was
analyzed. In comparison to the control and miR-137 inhibitor
transfected cells, miR-137 caused a significant drop in
proliferation rate (Fig. 4A), which was abolished when cells
were co-transfected with miR-137 inhibitor. We also investi-
gated whether the maintenance of self-renewal under normal
culturing conditions would be affected by increased miR-137
by analyzing the self-renewal marker alkaline phosphatase.
The loss of alkaline phosphatase staining was evident from as
early as 2 days after transfection. In comparison to the control
and miR-137 inhibitor, transfection of mature miR-137 RNA
duplexes induced changes in colony morphology and caused a
significant loss of alkaline phosphatase staining, indicative of
differentiation (Figs. 4B and C). These results indicate that
the significant drop in cell proliferation was caused by thedifferentiation of cells transfected with miR-137 and not by
cell death. To rule out the non-specific effects of mature
miR-137 RNA duplexes, we co-transfected duplexes with
miR-137 inhibitor, this completely prevented the loss of
alkaline phosphatase staining caused by miR-137 (Figs. 4B
and C). We also stained these cells for the self-renewal
marker, Nanog; LSD1, a direct target of miR-137; and
cytochrome c, as a control. As shown in Fig. 5, transfection
of mature miR-137 duplexes significantly reduced the levels
of Nanog and LSD1 (Fig. 5A) without affecting the levels of
cytochrome c in these cells (Fig. 5B). Taken together, our
results suggest that temporal expression of miR-137 plays
an important role in the normal cell cycle progression of ES
cells, and its continued expression most likely inhibits cell
proliferation.Overexpression of miR-137 induces differentiation
of ES cells in vitro
ES cells show the early stages of embryogenesis and can
differentiate into all three primary embryonic germ layers;
the endoderm, mesoderm, and ectoderm; depending on
culture conditions (Evans and Kaufman, 1981). Therefore,
we used EB cultures to determine the differentiation
potential of miR-137 in ES cells. We transfected the ES
cells growing on gelatin-coated plates under self-renewing
conditions with mature miR-137 RNA duplexes, miR-137
inhibitor, or a combination of both. After 24 h, cells were
trypsinized and allowed to form EBs (D0) onto non-adherent
bacterial culture plates in ES medium without the leukemia
inhibitory factor (LIF) for 4 days (D4) as described previously
(Nair, 2006). Transfection of ES cells with miR-137 caused
changes in EB morphology, characterized by the appearance
of a large number of flat cells with enlarged cytoplasm, even
when the cells were maintained in complete ES medium
without any differentiation-inducing agents (Fig. 6A). The
miR-137-induced morphological changes were completely
prevented by co-transfection with miR-137 inhibitor (Fig. 6A).
To test whether differentiation of EBs by miR-137 was
associated with the repression of Klf4, Tbx3, and LSD1, the
expression of these genes was analyzed by RT-qPCR. Consistent
with reported studies, the expression of ES cell markers Oct4,
Klf4, and Tbx3 was decreased in 4 day old EBs (D4) (Ivanova et
al., 2006; Martin-Ibanez et al., 2007; Sajini et al., 2012; Wei et
al., 2005; Zhang et al., 2010). Moreover, in EBs transfectedwith
miR-137, there was significant downregulation of Klf4, Tbx3,
and LSD1,without affecting the expression of Oct4 (Figs. 6B–E).
These results suggest that the repression of Klf4, Tbx3, and
LSD1 by miR-137 correlates with the increased differentiation
of ES cells. Furthermore, the upregulation of neuronal (Sox1
and Tuj1), endoderm (Foxa2 and Sox17), and mesoderm
(Brachyury and Mixl1) markers in cultures of EBs transfected
with mature miR-137 duplexes (Figs. 6F–K) suggests that
miR-137 accelerates the differentiation of ES cells into all
three lineages.
Previous studies have shown that miR-137 could inhibit
proliferation and induce differentiation of tumor cells
(Kozaki et al., 2008; Silber et al., 2008). Given that miR-137 is
essential for the maturation of neurons (Ripke et al., 2011;
Silber et al., 2008; Smrt et al., 2010; Sun et al., 2011a), we
next examined whether miR-137 induces differentiation of
Figure 4 Overexpression of miR-137 inhibits ES cell proliferation. (A) miR-137 significantly reduced cell proliferation. R1 ES cells
transfected with mature miR-137 RNA duplexes and cultured in complete ES medium with LIF for 4 days. The growth rate was
evaluated by CellTiter-Blue assay and the results are normalized to control ES cells (mean ± s.e.m., n = 8). (B) Alkaline phosphatase
staining of control, mature miR-137 RNA duplexes, miR-137 inhibitor, and a combination of both. Transfected R1 ES cells after being
cultured in complete ES medium with LIF for 5 days. (C) Relative numbers of alkaline phosphatase positive and negative colonies in
panel B. Mean ± SD from triplicate measurements are plotted.
1307MicroRNA-epresses Klf4 and Tbx3 during differentiation of mouse embryonic stem cellsES cells to a neuronal lineage. In EB differentiation assays,
we stained the cells for the expression of the neuronal
marker, Tuj1, and the miR-137 target, LSD1. As shown in
Fig. 7, we observed a significant increase in the number of
cells that express Tuj1 following transfection with miR-137
mimic. Moreover, the Tuj1-positive cells also showed
cellular morphology characteristics of differentiation (flat
and elongated cells) and low levels of LSD1 (Figs. 7A and B).
miR-137-induced morphological changes, the induction of
Tuj1, and the repression of LSD1 were prevented when cells
were cotransfected with miR-137 inhibitor (Figs. 7A and B).These data together suggest that miR-137 accelerates
differentiation of ES cells by repressing its targets, including
Klf4, Tbx3, and LSD1.
To further confirm the involvement of miR-137 in
neurogenesis, we tested whether downregulation of miR-137
could impair the differentiation of ES cells into neurons. To
inactivate the endogenous miR-137 during differentiation, ES
cells were transfected with miR-137 inhibitor or a control
inhibitor, allowed to form EBs, and then differentiated into
neurons by culturing for 12 days (Nair, 2006). Transfection of
miR-137 inhibitor dramatically decreased the percentage of
Figure 5 Overexpression of miR-137 represses the expression of self-renewal marker Nanog in ES cells. R1 ES cells were transfected
with mature miR-137 RNA duplexes or miR-137 inhibitor and cultured in complete ES medium with LIF for 5 days. The cells were
stained with antibodies to Nanog (red) and LSD1 (green) (A) or with Nanog (red) and cytochrome c (green) (B). Representative images
were shown.
1308 K. Jiang et al.Tuj1-positive cells; Tuj1-positive staining was mainly observed
in rounded cells compared to the control and cells transfected
with a control inhibitor (Figs. 8A and B). The differentiated
cells (NC) also expressed low levels of the Klf4, Tbx3, and
LSD1 proteins, compared to undifferentiated ES cells (ESC)
(Fig. 8C). To further determine the contribution of miR-137 in
the differentiation of ES cells to neurons, we assessed the
expression of ES cell and neuronal genes in differentiated cells
transfected with miR-137 inhibitor by RT-qPCR. The ES cell
transcription factors were expressed at very low levels or
were undetectable when ES cells were differentiated into
neuronal cells (Figs. 8D–H). In contrast, many of the neuronal
transporters and channels were highly expressed in differ-
entiated neurons (Figs. 8L–Q). The inhibition of miR-137
significantly impaired the downregulation of Klf4, Tbx3,
and LSD1 (Figs. 8G–I). A small but significant increase in the
levels of Nanog, Oct4, and Sox2 was also observed in
miR-137 inhibited cells (Figs. 8D–E). The increased levels of
pluripotency factors in miR-137 inhibited cells were also
correlated with decreased levels of neuronal genes such as
Calb1, Kcnn1, Scn3a, Slc1a3, and NeuroG2. No changes in the
levels of CoRESTwere observed in any of the treatment groups
(Fig. 8K). This suggests that miR-137 is involved in the proper
gene expression and maturation of neurons, at least in our in
vitro differentiation system.
Discussion
In the present study, we have shown that miR-137, a
neuronally-enriched miRNA, is expressed in ES cells at the
mitotic phase of the cell cycle and its expression is highly
upregulated during differentiation into the neuronal linage.
We uncovered a direct link between miR-137 and ES celltranscription factors, Klf4 and Tbx3. It appears that miR-137
has a dual function in ES cells depending on their expression
status. While its expression in the mitotic phase indicates
that miR-137 is involved in cell division, increased levels of
the miRNA during differentiation appear to be involved in
the maturation of ES cell-derived neurons. The data could
indicate that the dynamic responses of miR-137 seem to be
involved in mediating the balance between self-renewal and
differentiation by regulating the expression levels of its direct
targets, including Kfl4, Tbx3, and LSD1; and indirectly Nanog,
Sox2, and possibly others. Our findings are consistent with the
reports that miRNAs promote mouse ES cell differentiation
through posttranscriptional attenuation of key ES cell tran-
scription factors (Tay et al., 2008; Xu et al., 2009).
miR-137 is a known regulator of neuronal development
and its expression has been found to increase during
neuronal differentiation (Ripke et al., 2011; Silber et al.,
2008; Smrt et al., 2010; Sun et al., 2011a). This study
demonstrates that miR-137 has a role in ES cell proliferation
and differentiation. We have shown that miR-137 is
expressed in ES cells in a cell cycle-dependent manner and
is highly upregulated during differentiation of ES cells into
neuronal linage. These results suggest that miR-137 may be
involved in cell cycle progression or differentiation
depending on the cellular context it is expressed in. This
finding is consistent with previous reports, which show that
miR-137 negatively regulates cell proliferation and accel-
erates neural differentiation of embryonic neural stem cells
(Silber et al., 2008; Sun et al., 2011b). miR-137 has been
shown to mediate differentiation by targeting many genes
including CDK6, a regulator of the cell cycle and dif-
ferentiation (Silber et al., 2008); Ezh2, a histone
methyltransferase (Szulwach et al., 2010); Jarid1b, a
Figure 6 Overexpression of miR-137 promotes differentiation of embryonic stem cells and represses Klf4, Tbx3, and LSD1.
(A) Phase-contrast images showing the morphologies of EBs at day 4. Control (top left); miR-137 (top right); miR-137 inhibitor (bottom
left); combination of both (bottom right). (B–E) RT-qPCR analysis of relative Klf4, Tbx3, LSD1, and Oct4 expression levels in EBs at
days 0, 2, and 4. The R1 ES cells growing on gelatin coated plates were transfected with mature miR-137 duplexes, inhibitor, or a
combination of both. After 24 h (Day 0), cells were dissociated and plated in a non-adherent plate to form EBs for 4 days (D4). The
expression levels of each gene in the control at indicated days were arbitrarily set to one. The relative expression levels in EBs
transfected with mature miR-137 RNA duplexes, miR-137 inhibitor, or a combination of both were normalized to the control mRNA
levels of the corresponding day. The gene expression of Klf4 (B), Tbx3 (C), and LSD1 (D) was significantly repressed in miR-137
transfected cells, whereas the repression was completely prevented when cells were cotransfected with both miR-137 and miR-137
inhibitor. (F–K) RT-qPCR analysis of neuronal (Sox1 and Tuj1), endoderm (Foxa2 and Sox17), and mesoderm (Brachyury and Mixl1)
markers in EBs transfected with mature miR-137 duplexes. All RT-qPCR experiments were performed three times in triplicate and the
error bars denote SD. *, P b 0.001.
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Mib1, a ubiquitin ligase (Smrt et al., 2010); and TLX, an
orphan nuclear receptor (Sun et al., 2011b). In this study,
we showed that miR-137 is also able to target the 3′UTRs of
Klf4 and Tbx3 and regulate self-renewal and differentiation
of ES cells.
Previously, LSD1 was identified as a miR-137 target in
the neural stem cells of embryonic brains (Sun et al.,
2011b) and in colorectal cancer cells (Balaguer et al.,
2010). The interaction between miR-137 and LSD1 has been
shown to play a critical role in the molecular circuitry
controlling neural stem cell proliferation and differentiation
during neural development (Sun et al., 2011b). Recent reports
have demonstrated that high levels of LSD1 are needed to
maintain the undifferentiated state of embryonic stem cells,and its expression has been shown to be downregulated during
ES cell differentiation (Adamo et al., 2011). In ES cells, we
found that miR-137 also targets the transcription factors, Klf4
and Tbx3, in addition to LSD1. Transfection of maturemiR-137
RNA duplexes into ES cells caused the repression of the Klf4,
Tbx3, and LSD1 3′UTR assays; downregulation of endogenous
Klf4, Tbx3, and LSD1 mRNA and proteins; and triggered
premature differentiation in our EB assays. The cotransfection
of miR-137 and miR-137 inhibitor completely abolished the
gene repression and differentiation mediated by the miR-137.
The inhibition of miR-137 impeded the dendritic morphogen-
esis and phenotypic maturation of ES cell-derived neurons,
and the altered gene expression in these cells further suggests
an important role for miR-137 in the differentiation of ES cells
in vitro.
Figure 7 miR-137 promotes differentiation of ES cells toward a neuronal lineage. (A–B) Immunocytochemical staining demonstrates
the differentiation of R1 ES cells transfected with the mature miR-137 RNA duplexes, miR-137 inhibitor, or a combination of both, 4 days
after EB formation (5 days after transfection). Cells were stained for LSD1 (red) and Tuj1 (green). Lower (A) and higher (B) magnifications
are shown. Scale bar, 250 and 40 μm, respectively.
1310 K. Jiang et al.Klf4 encodes a krűppel-like zincfinger transcription factor,
which is required for the establishment of pluripotency in
somatic cells (Takahashi and Yamanaka, 2006). Tbx3 has been
reported tomaintain ES cell self-renewal (Ivanova et al., 2006);
and sustained expression of Tbx3 is sufficient to maintain ES
cells in an undifferentiated state in the absence of LIF (Niwa et
al., 2009). In mouse ES cells, the transcription factor, Klf4, is
mainly activated by the Jak–Stat3 pathway and preferentially
activates Sox2; whereas, Tbx3 is preferentially regulated by the
phosphatidylinositol-3-OH kinase–Akt and mitogen-activated
protein kinase pathways and predominantly stimulates Nanog
(Niwa et al., 2009; Zhang et al., 2010). However, activation of
Klf4 and Tbx3 is not required for the expression of Oct4 in ES
cells (Niwa et al., 2009). We showed that miR-137 also
represses Nanog and Sox2 without affecting the expression of
Oct4 in these cells. However, both Nanog and Sox2 lackmiR-137
target sites; and miR-137 failed to repress Sox2 3′UTR activity.
Our results suggest that miR-137 targets components of the
self-renewal pathway in ES cells in order to promote differen-
tiation by repressing Klf4 and Tbx3, which may indirectly
downregulate Sox2 and Nanog.
The downregulation of miR-137 in numerous cancers
(Balaguer et al., 2010; Chen et al., 2010; Silber et al., 2008),
as well as our findings that miR-137 induces differentiation
of ES cells, raises the possibility that miR-137 functions as
a pro-differentiation factor in a lineage-specific fashiondepending on the cellular context. The targeting of Klf4, Tbx3,
and LSD1 supports this notion, as Klf4, Tbx3, and LSD1 are
highly expressed in undifferentiated ES cells and inmany forms
of cancers (Fillmore et al., 2010; Hayami et al., 2011; Lim et
al., 2010; Lomnytska et al., 2006; Lv et al., 2012; Renard et
al., 2007; Schulte et al., 2009; Vance et al., 2005; Wei et al.,
2010). Recent evidence indicates that miR-137 represses LSD1
in human carcinoma cells and in mouse neural stem cells
as they begin to differentiate and is required for normal
differentiation (Balaguer et al., 2010; Sun et al., 2011b). Klf4 is
one of the four factors that, together, are sufficient to
reprogram human fibroblasts into pluripotent cells (Takahashi
and Yamanaka, 2006); and the overexpression of Tbx3 has
been shown to increase the efficiency of the derivation of
induced pluripotent stem cells (Han et al., 2010). It would be
interesting to determine, though, whether elevated miR-137
in mitotic cells is a factor of self-renewal or is involved in
differentiation, as demonstrated by the overexpression of
miR-137 in non-dividing cells.Conclusions
Here, we show that miR-137 is highly expressed in M phase ES
cells and shows increased expression in differentiated neuro-
nal cells. We also demonstrate that the increased expression
Figure 8 miR-137 participates in neuronal differentiation of mouse R1 ES cells. (A) Immunostaining for Tuj1 (green) and histone H3
(red) was performed at day 12 of differentiation, showing typical neurite formation in control (right panel) and cells transfected with
a control inhibitor (left panel). The same analysis was performed in cells transfected with miR-137 inhibitor (middle panel) and shows
a reduction in Tuj1 immunoreactivity, together with reductions in neurite outgrowth. Representative photomicrographs are
shown. (B) Tuj1-positive cells in control; cells transfected with control inhibitor or miR-137 inhibitor were counted at day 12 of
differentiation and expressed as percentage to control (mock-transfected) cells. The average of three culture replicates for each
combination is shown, with error bar indicating the SD. *, P b 0.001. (C) Representative Western blots showing the levels of indicated
proteins in ES cells and neuronally differentiated cells for 12 days. (D–Q) RT-qPCR analysis to examine the expression levels of ES cells and
neuronal genes in cells transfected with control and miR-137 inhibitor at day 12 of differentiation. Transcript levels were normalized
using β-actin, α-tubulin, and rps11 in these cells and comparedwith the levels in ES cells or neuronally differentiated ES cells for 12 days.
All RT-qPCR experiments were performed two times in triplicate and the error bars represent SD. *, P b 0.001.
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1312 K. Jiang et al.of miR-137 attenuates the levels of Klf4, Tbx3, and LSD1
during differentiation and its inhibition upregulates these
genes and disrupts neuronal maturation. Our results indicate
that miR-137 plays a role in the maintenance and differenti-
ation of ES cells.
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